| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||
Screening and monitoring of cancer. Ed. by B. A. Stoll, pp. 440, 1985 (John Wiley, Chichester), £44.50. ISBN 471–90483–X
This excerpt was created in the absence of an abstract.
Despite enormous research efforts there has been little change in the end results of our treatment of most of the common cancers over the last thirty years. Fashions of patient management have come and gone but the survival of patients with lung, colorectal and breast cancer remains consistently dismal once the disease has metastasised. Although there are hints of a new understanding of the biology of cancer emerging from the application of techniques such as genetic engineering, there is little promise of immediate therapeutic benefit round the corner. For these reasons it is appropriate to consider new strategies for screening populations at risk in order to detect early disease, and treated patients for evidence of early relapse.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |